Harmony Biosciences Holdings Inc (HRMY)
ROA
Obliczenia
|
2023 (31 gru 2023) |
2022 (31 gru 2022) |
2021 (31 gru 2021) |
2020 (31 gru 2020) |
||
|---|---|---|---|---|---|
| Zysk netto | w tys. USD | 128 853 | 181 468 | 34 597 | -63 848 |
| Aktywa razem | w tys. USD | 811 448 | 673 870 | 433 443 | 427 074 |
| ROA | 15,88% | 26,93% | 7,98% | -14,95% |
2023 obliczenia
ROA = Zysk netto ÷ Aktywa razem
= $128 853K ÷ $811 448K
= 15,88%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROA
Harmony Biosciences Holdings Inc
HRMY
15,88%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Arcus Biosciences Inc
RCUS
-28,04%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Corcept Therapeutics Inc
CORT
17,08%
Dynavax Technologies Corp.
DVAX
-0,64%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Myriad Genetics, Inc.
MYGN
-22,97%
Pacira BioSciences Inc
PCRX
2,66%
Supernus Pharmaceuticals Inc
SUPN
0,10%
Xencor Inc
XNCR
-13,23%